Clinerion Continues Expansion of Patient Network Explorer in South America
Clinerion’s Partnership with the company B-TRIALS will drive the expansion of Patient Network Explorer’s coverage in Chile, thereby bringing greater access to innovative treatments to patients in the country.
The Chilean company B-TRIALS will be responsible for the expansion of Clinerion in Chile. This will give patients in Chile better access to innovative medical treatments.
B-TRIALS, founded by pharmacists Pablo García and Ricardo Cuevas, offers a wide variety of services to the different stakeholders of clinical research, including multi-channel recruitment, clinical trial monitoring, clinical trial coordination, pharmacovigilance, quality control, regulatory affairs, data management, etc.
Patient Network Explorer supports patient health by matching patients to trials conducted by clinical trial sponsors or researchers performing academic investigations.
"The implementation of the Clinerion’s Patient Network Explorer platform in hospitals and clinics, added to the quality of the specialist physicians in Chile, can lead the country to be a reference in clinical research and B-TRIALS will be the gear to make this happen," says Pablo Garcia, Commercial Director of B-TRIALS.
“Chile is characterized by being a benchmark in quality and having the highest rate of studies per inhabitants in Latin America, as well as being one of the fastest growing economies in Latin America according to the World Bank. Sufficient reasons for Clinerion to have a presence in this country and bring our digital technology to the benefit of patients here,” says Ian Rentsch, CEO of Clinerion.
For more go to www.clinerion.com
FDA Finalizes Decentralized Clinical Trial Guidance
November 25th 2024The FDA's guidance is part of a broader effort to modernize clinical trials, improve efficiency, reduce participant burden, and expand access, particularly for underrepresented populations and those in geographically or economically constrained areas.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
